Background-Historically, smoking cessation was thought to negatively impact substance use outcomes among smokers who use other substances. We sought to synthesize recent reports on this association.
Introduction
Smoking rates are two to four times higher among adolescents and adults with substance use disorders (SUD) compared to the general population. [1] [2] [3] Still, smoking cessation treatment is not included in most SUD treatment settings 4, 5 and there is a dearth of reporting on the impact of quitting smoking on substance use behaviors in non-treatment seeking populations. Smoking has had a steady, long-term relationship with both clinicians and patients in substance use and mental health treatment settings, making these settings less receptive to smoking cessation treatment and less supportive of quitting than providers in general medical facilities or the community. 6, 7 Historically, smoking was allowed and even encouraged in addiction treatment programs and in mental health units, the pervasive rationale being that tobacco was a lower treatment priority and/or a less harmful alternative to other substance use. 5, 8, 9 Arguments proffered by treatment providers included if their patients quit tobacco they would relapse on other substances of abuse, their depression would recur and/or they would otherwise decompensate. 10 Meanwhile, just below the surface, the tobacco industry was marketing cigarettes to persons with mental illness and providing tax-free cigarettes to treatment facilities 11 where cigarettes were provided to patients, facilitating smoking initiation, while hospitalized, for some formerly nonsmoking patients. 12, 13 Finally, many staff and clinicians in the fields of drug abuse treatment and mental health are smokers, which serves to both perpetuate the habit and stem implementation of smoking cessation programs and smoke free policies in these settings. [14] [15] [16] [17] Many adults and adolescents attend 12-step fellowship meetings such as Alcoholics Anonymous or Narcotics Anonymous to achieve abstinence or as a form of relapse prevention upon completion of formal SUD treatment. 18, 19 The 12-step philosophy, which teaches that the first and primary responsibility is sobriety from alcohol, illegal drugs, and non-prescription medications, [20] [21] [22] can further perpetuate continued smoking by recommending members focus and not make too many additional changes (i.e. quitting smoking). [21] [22] [23] Meetings often allow or encourage smoking as a form of "fellowshipping" to enhance recovery, thereby helping to maintain smoking and nicotine dependence among individuals who report use of other substances. 24, 25 Evidence is mounting that the harms of tobacco use far outweigh any perceived benefit in the context of substance use or SUD treatment. For example, adolescent substance users who smoke are more likely to continue smoking in adulthood 26 and far more deaths among adults reporting alcohol and drug use are due to smoking than to alcohol and all other drugs combined. 27 In 2004, a meta-analysis of smoking cessation intervention studies conducted among individuals in SUD treatment or recovery found that cessation interventions offered concurrently with addictions treatment were associated with a 25% increased likelihood of long-term drug and alcohol abstinence. 28 Thus, fears associated with smoking cessation among people with SUD may be unwarranted.
Studies have increasingly addressed smoking cessation in the context of SUD treatment over the last decade. Strategies for promoting smoking cessation have included delivering cessation programs to individuals in SUD treatment and implementing and enforcing smoking bans in adult and adolescent treatment facilities. [29] [30] [31] In 2010, two literature reviews summarized the evidence on the effects of smoking cessation in the context of SUD treatment: one among those in treatment for or in early remission from alcohol dependence 32 ; and one in addiction and mental health treatment settings. 10 Both studies found improved rather than worsened substance use treatment outcomes related to smoking cessation intervention. In 2015, a systematic review of randomized controlled trials that included impact of smoking cessation treatment on substance use outcomes among those in early recovery from or in treatment for SUD reported either no impact on or improvement in substance use treatment outcomes. 33 With limited extant research, no reviews among adolescent populations were identified. One study (2007) conducted in adolescent residential substance use treatment programs assessed the relationship between program-level policies and client-level smoking, and showed increases in stringency of smoke-free policy were associated with decreases in smoking prevalence. 34 These findings suggest addressing tobacco use in the context of addiction treatment and recovery may afford patients multiple health benefits now and in the future.
Here, we provide an updated review and interpretation of the most current knowledge by reviewing reports from the last decade (January 2006 through March 2016) on the impact of formalized smoking cessation treatment or of quitting smoking/former smoker status on substance use outcomes. By synthesizing recent findings and including studies with adolescents, reports from epidemiological studies, and results from pilot studies and secondary analyses, we fill important gaps in the extant literature. Whereas reports from 2010 32 and 2015 33 have addressed solely formal smoking cessation treatment interventions among those in treatment for or recovery from substance use (including alcohol) this report includes findings among non-SUD treatment seeking populations including reports published from 2015 through March, 2016 as well. This allows for a broader, more inclusive view of the overarching impact of smoking cessation and quitting smoking on substance use outcomes.
Methods
Articles published in print or online between January 1, 2006 and March 29, 2016 were identified through electronic searches of Google Scholar, PubMed, and Cinahl. Google Scholar was chosen for breadth and as a more novel search tool; PubMed as a standard search engine; and Cinahl for its inclusion of peer-reviewed nursing and nursing practice journals not easily identified elsewhere. Search criteria combined the terms "smoking" "cessation" "substance" "drug," and "alcohol." Study title, abstracts, and bodies were reviewed by KM and JT to determine study inclusion. Selection was restricted to English language studies that: (a) established temporality (i.e. cross sectional studies were excluded), (b) listed at least one outcome related to substance use, SUD, or SUD treatment, and (c) identified quitting smoking ("former smoker status") or a smoking cessation treatment intervention as an independent variable. To avoid duplicative reporting and in light of the similarity in conclusions drawn by the three reviews conducted over the past decade 10, 32, 33 the reviews and the studies included within were omitted.
Titles of the first 100 citations in Google Scholar were scanned and 35 unique and potentially relevant citations were identified. Google Scholar has been found to have recall and precision comparable or superior to more traditional databases when the first 100 citations are considered (over 84,000 citations were identified in the instant search). 35 PubMed and Cinahl were then searched using the same search terms and resulted in 50 unique citations (35 and 15, respectively). No additional studies were identified through bibliographic searches. The 85 articles identified were read by JT and KM to ascertain if they met inclusion criteria and 24 studies were included in the review.
As the 24 selected studies showed considerable heterogeneity in terms of measurement of smoking cessation intervention or quit status, outcome variables, and analyses, it was not feasible to conduct a meta-analysis focused on effect size. 36 In accordance with the "principle of best evidence," 37 we did not discard studies without the information necessary for formal quantification since they still provide valuable and relevant evidence. We then appraised each study for overall impact on substance use outcomes as positive, null, mixed, or negative. Within each study, impact was assessed for each reported substance use outcome. Overall impact was deemed "positive" if only improvements were reported on all substance-related outcomes assessed (e.g. increased length of time to relapse, decreased number of days using drugs). "Null" impact was assigned if no change in any substance use outcomes was reported. A "negative" impact was assigned if worse substance use outcomes were found (e.g. shorter term of abstinence). A "mixed" impact was assigned if there were differences in the direction of individual outcomes within a study.
Results
Twenty-four studies (25 study populations as one study [Lisha, et al., 2014] included two samples) reported the impact of quitting smoking (n = 18) or of smoking cessation treatment intervention, independent of quitting smoking, (n = 6) on substance use outcomes ( Table 1) . Fourteen studies were among SUD treatment samples (five among adolescents); two in household survey samples, one in a school-based survey sample (among adolescents); four among samples seeking smoking cessation treatment; and one each of high-needs population samples: HIV positive patients, homeless smokers, and smokers in mental health outpatient and inpatient (adolescent) treatment ( Figure 1 ).
Positive Findings
Eleven of 24 studies (46%) reported positive findings regarding the impact of quitting smoking (n=9) 38-46 and of smoking cessation treatment interventions (n=2) 29,47 on substance use outcomes. Of these, five were among patients in SUD treatment-42-46 of which two targeted adolescents, 43,44 four were among participants delivered smoking cessation interventions, 29, 38, 41, 47 of which one study targeted adolescents during psychiatric hospitalization, 29 and two were among adult general population samples. 39, 40 (Figure 2) Of the 11 studies with positive findings, eight (73%) found improved alcohol-specific outcomes of fewer drinks per day, 38 fewer drinks per week, 47 decreased likelihood of relapse, 43 increased abstinence for 12 months 40,42 and for 30 days, 45 increased likelihood of "alcohol-abstainer" trajectory membership, 44 and decreased likelihood of being diagnosed with alcohol use disorder. 39 Five studies (45%) reported drug-specific outcomes or general "drug" outcomes that excluded alcohol; one found increased likelihood of past year abstinence from drugs, 42 one found decreased likelihood of being diagnosed with a drug use disorder, 39 two found improved marijuana-specific outcomes of reduced percent of using days 47 and decreased likelihood of relapse and longer time to relapse 43 and one found reduced stimulant craving. 46 Finally, among studies that reported improved combined (e.g. alcohol and other drugs) substance use outcomes (n = 4; 36%), findings of decreased likelihood of SUD diagnosis, 41 past-year remission, 42 decreased escalation of use posttreatment, 29 and increased likelihood of past 30-day abstinence and lower addiction severity index (ASI) scores 45 were found.
Null Findings
Four studies (17%) reported an overall null impact on substance use outcomes. Study designs varied (pro-and retrospective cohort studies and RCT) as did outcomes: drinking and drug use behavior, treatment enrollment and completion, study attendance and adherence. Sample populations also varied widely: general population adults, and adolescents, adults in SUD treatment, adolescents in SUD treatment., and adults seeking smoking cessation treatment. The studies investigated quitting smoking as well as effects of different smoking cessation interventions (implementation of a smoking ban, contingent vs. non-contingent vouchers crossed with motivational interviewing or brief advice, contingency management vs. behavioral support).
One study reported no change in the alcohol-specific outcomes of binge-and overall drinking frequency. 48 Another found no difference in SUD treatment enrollment or completion. 30 The third study showed no difference in reported number of heavy drinking days, number of drug use days, and instances of reported relapse. 49 The fourth study found no differences in study attendance and adherence and no difference in reported and verified substance use abstinence. 50 Given the sample sizes of 45 (Alessi & Petry, 2014), 54 (Myers & Prochaska, 2004) , and 184 (Rohsenow, et al., 2015), it is possible (but not likely) that the null findings were due to small sample sizes and thus low power to detect an effect.
Mixed Findings
Nine studies (38%) reported mixed findings: eight studies (89%) reported mixed positive and null impact by analysis (combined and subgroup, n = 1) 51 ; type of substance (n = 4) 11,52-54 ; length of follow-up (n = 2) 55,56 ; and comparison group (n = 1). 57 Six studies 11,51-54,57 addressed quitting smoking and three were smoking cessation treatment interventions. 55,56,58 Five were among SUD treatment seeking samples, 51,53,54,56,58 three were among adolescents, 54,56,57 two in general population samples, 55,57 one among a smoking-cessation treatment-seeking (but not SUD treatment seeking) sample, and three among high-needs populations (an HIV clinic sample (of HIV+ patients), a homeless smokers sample, and a sample of smokers in mental health outpatient treatment). While all nine reported at least one substance use outcome that was not impacted, eight reported at least one substance use outcome that was positively impacted 11,51-57 and only one reported a negatively impacted substance use outcome. 58 Considering substance use outcomes, six reported alcohol-specific outcomes (either alone or in combination with other substance use outcomes), three of which had findings both positive and null for the same alcohol-specific outcomes, two had findings of positive impact, and one reported no impact. Both positive and no impact was reported regarding number of drinks, 51 prevalence of binge drinking, 55 and odds of reporting alcohol (or illicit drug) dependence. 57 The direction of these findings depended on the group analyzed, length of follow-up, and comparison group, in that order. Two studies reported impacts resulting solely in positive alcohol-related outcomes of decreased use 11 and decreased number of drinks and drinking days as well as lower odds of heavy drinking. 52 These same studies, however, found no impact on drug use or number of days using drugs, respectively. One study reported no impact on odds of reporting alcohol abstinence and positive impact/ increased odds of reporting abstinence from drugs. 54 Only one study did not separate alcohol from other drug outcomes and instead reported on "substance use" outcomes. 56 Here, the positive impact of decreased number of substance use days at 3 months follow-up was not found at 6 months (no impact). There was also a single study that reported higher average percent of abstinent weeks among cocaine dependent (positive impact), but not methamphetamine dependent (no impact), individuals. 53 Finally, one study reported decreased alcohol abstinence (negative impact) for Caucasian participants who received smoking cessation treatment concurrent with alcohol use treatment compared to those who received smoking cessation treatment 6 months after alcohol use treatment, the same was not true for African American participants (no impact). 58
Discussion
We reviewed the published evidence from the last decade reporting the impact of quitting smoking and/or smoking cessation treatment intervention on substance use outcomes. Across 24 studies, both quitting smoking and smoking cessation treatment intervention had either a positive impact or no impact on substance use outcomes. Positive impact was reported for a range of alcohol use outcomes (e.g., number of drinks, alcohol abstinence, and alcohol use disorder diagnosis) as well as drug use outcomes (e.g., using days, relapse, remission, SUD diagnosis). Importantly, for those in SUD treatment, neither forced quit attempt (smoke-free policy) nor smoking cessation treatment intervention type (e.g. brief advice to quit, motivational interviewing, and offering vs. not offering nicotine replacement) affected treatment outcomes. Results support the broad delivery of smoking cessation intervention in accordance with clinical practice guidelines 59 (offering advice to quit, using medications, and enrollment in smoking cessation counseling) to any individual that reports alcohol or other drug use (whether recreational, disordered, or otherwise). Further, if patients are able to quit smoking, it may make it easier for them to change other substance use for a variety of reasons.
Only one study reported a negative impact of smoking cessation on a substance use outcome. 58 A secondary analysis of data from a 2004 study by Joseph and colleagues 60 found smoking cessation treatment delayed by 6 months was associated with longer alcohol abstinence than smoking cessation treatment implemented concurrently with alcohol treatment, but only for Caucasian (not African-American) participants. 58 Results cannot be generalized to the general population of smokers with alcohol use disorders.
It is evident that neither quitting smoking nor smoking cessation treatment-intervention results in worsening substance use outcomes (e.g. increased rates of relapse to alcohol or other drugs), even absent direct comparisons. For example, one study found participants who quit smoking reported less craving for stimulants (elimination of craving coupling) 46 while two others (an RCT and analysis of a large prospective cohort) found those who quit smoking were less likely to have incident SUD diagnoses. 33, 35 Further, if patients are able to quit smoking, it may make it easier for them to change other substance use.
Some limitations of this review bear noting. First, review was restricted to studies published in English. Second, findings in reviewed studies were limited to those the authors chose to publish. Third, meta-analysis was not conducted due to heterogeneity of outcomes, measurements, and sample characteristics. Fourth, studies reporting the impact of quitting smoking, or of "former smoker" status did not differentiate between former smokers who quit on their own and those who may have participated in a formal smoking cessation treatment intervention.
Conclusions
When considered in conjunction with the known, undisputed harms of smoking, 61 this review provides support for policies encouraging quitting among smokers in SUD treatment settings and the offering of formal smoking cessation treatment or advice to quit, including cessation aids, to smokers who report use of other substances, whether or not they are seeking SUD treatment. Additionally, since provider barriers to offering smoking cessation treatment options and strategies to patients is often cited, 62,63 this review also provides support for broad delivery of clinician training in smoking cessation treatment and support. The integration of such practices and policies will improve the health and wellbeing not only of substance using populations, but also of their families and friends-now and for future generations. Failing to do so is tantamount to increased harm. 
